Cencora Inc. stock: Argus raises target to USD 380 pre-market

Published on 10/21/2026 at 07:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cencora provides distribution, commercialization, patient access, and pharmacy solutions. At Lang & Schwarz the stock trades pre-market at EUR 306.30 on October 21, 2026.

Analyst action and current trading

Argus raised its Cencora price target to USD 380 on October 20, 2026.
Cencora's website describes four solution areas: distribution, commercialization, patient access, and pharmacy solutions.
Cencora Inc. stock trades pre-market at EUR 306.30 at 7:54 a.m. CEST at Lang & Schwarz on October 21, 2026.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks — Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Argus raised its price target for Cencora Inc. to USD 380 on October 20, 2026, while maintaining a Buy rating, according to Investing.com. Cencora Inc. stock trades pre-market at EUR 306.30 at 7:54 a.m. CEST at Lang & Schwarz on October 21, 2026.

Argus revises valuation

Investing.com reported that Argus lifted its Cencora target to USD 380 and retained its Buy rating. The report identified prescription-drug volume growth and mergers and acquisitions as factors cited by the firm.

Business and market context

Cencora's website describes four solution areas: distribution, commercialization, patient access, and pharmacy solutions for manufacturers, providers, and health systems. Market context: Market report S&P 500.